UK markets close in 5 hours 49 minutes

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.5250+0.0450 (+1.81%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.67-0.6-2.39-1.98
Low estimate-0.74-0.72-2.84-2.61
High estimate-0.57-0.37-1.57-0.89
Year ago EPS0.4-1.07-3.75-2.39
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate350k400k1.83M5.9M
Low estimate300k300k1.1M2.61M
High estimate400k500k2.6M8.5M
Year ago sales297k463k1.5M1.83M
Sales growth (year/est)17.80%-13.60%21.80%222.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.84-1.3-1.01-1.14
Actual EPS0.4-1.07-0.81-2.12
Difference2.240.230.2-0.98
Surprise %121.70%17.70%19.80%-86.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.67-0.6-2.39-1.98
7 days ago-0.65-0.54-2.2-1.75
30 days ago-0.76-0.61-3.01-2.43
60 days ago-0.76-0.61-3.01-2.43
90 days ago-0.76-0.61-3.01-2.43
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesOCXIndustrySector(s)S&P 500
Current qtr.-267.50%N/AN/AN/A
Next qtr.43.90%N/AN/AN/A
Current year36.30%N/AN/AN/A
Next year17.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A